blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2663342

EP2663342 - STABLE HYDROGEL COMPOSITIONS INCLUDING PHENYLEPHRINE [Right-click to bookmark this link]
Former [2013/47]STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES
[2019/40]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 23.04.2024
FormerThe patent has been granted
Status updated on  21.02.2020
FormerGrant of patent is intended
Status updated on  01.10.2019
FormerExamination is in progress
Status updated on  04.07.2017
Most recent event   Tooltip02.06.2023Lapse of the patent in a contracting state
New state(s): HU
published on 05.07.2023  [2023/27]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
For all designated states
Allergan Industrie, SAS
Route de Promery
Zone Artisanale de Pré-Mairy
Pringy
74370 Annecy / FR
[2020/33]
Former [2020/13]For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
For all designated states
Allergan Industrie, SAS
Route de Promery
Zone Artisanale de Pre-Mairy
74370 Pringy / FR
Former [2013/47]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, CA 92612 / US
For all designated states
Allergan Industrie, SAS
Route de Promery
One Artisanale de Pre-Mairy
74370 Pringy / FR
Inventor(s)01 / GOUSSE, Cecile
836 route de Thones
74230 Dingy Saint Clair / FR
02 / LEBRETON, Pierre, F.
7 rue Louis Revon
74000 Annecy / FR
03 / PROST, Nicolas
30 rue Victor Hugo
69440 Mornant / FR
04 / PALIWAL, Sumit
7220 Davenport Road
Goleta CA 93117 / US
05 / VAN EPPS, Dennis, E.
235 Elderberry Drive
Goleta CA 93117 / US
 [2020/13]
Former [2013/47]01 / GOUSSE, Cecile
836 route de Thones
F-74230 Dingy Saint Clair / FR
02 / LEBRETON, Pierre, F.
7 rue Louis Revon
F-74000 Annecy / FR
03 / PROST, Nicolas
30 rue Victor Hugo
F-69440 Mornant / FR
04 / PALIWAL, Sumit
7220 Davenport Road
Goleta CA 93117 / US
05 / VAN EPPS, Dennis, E.
235 Elderberry Drive
Goleta CA 93117 / US
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2020/13]
Former [2013/47]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12703634.113.01.2012
[2020/13]
WO2012US21278
Priority number, dateWO2011IB0005213.01.2011         Original published format: PCT/IB2011/000052
[2013/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012097272
Date:19.07.2012
Language:EN
[2012/29]
Type: A1 Application with search report 
No.:EP2663342
Date:20.11.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 19.07.2012 takes the place of the publication of the European patent application.
[2013/47]
Type: B1 Patent specification 
No.:EP2663342
Date:25.03.2020
Language:EN
[2020/13]
Search report(s)International search report - published on:EP19.07.2012
ClassificationIPC:A61L27/20, A61L27/54, A61L27/52
[2013/47]
CPC:
A61L27/54 (EP,KR); A61L27/20 (EP,KR); A61L27/52 (EP,KR);
A61L2300/436 (EP); A61L2400/06 (EP)
C-Set:
A61L27/20, C08L5/08 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/47]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:STABILE HYDROGELZUSAMMENSETZUNGEN MIT ZUSATZSTOFFEN[2013/47]
English:STABLE HYDROGEL COMPOSITIONS INCLUDING PHENYLEPHRINE[2019/40]
French:COMPOSITIONS D'HYDROGEL STABLE INCLUANT DES ADDITIFS[2013/47]
Former [2013/47]STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES
Entry into regional phase29.07.2013National basic fee paid 
29.07.2013Designation fee(s) paid 
29.07.2013Examination fee paid 
Examination procedure29.07.2013Examination requested  [2013/47]
06.03.2014Amendment by applicant (claims and/or description)
05.06.2014Despatch of a communication from the examining division (Time limit: M06)
30.10.2014Reply to a communication from the examining division
11.09.2015Despatch of a communication from the examining division (Time limit: M06)
03.03.2016Reply to a communication from the examining division
20.06.2017Despatch of a communication from the examining division (Time limit: M04)
18.10.2017Reply to a communication from the examining division
16.07.2018Despatch of a communication from the examining division (Time limit: M02)
24.09.2018Reply to a communication from the examining division
02.10.2019Communication of intention to grant the patent
10.02.2020Fee for grant paid
10.02.2020Fee for publishing/printing paid
10.02.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20162051.5  / EP3682911
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.06.2014
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Fees paidRenewal fee
27.01.2014Renewal fee patent year 03
27.01.2015Renewal fee patent year 04
27.01.2016Renewal fee patent year 05
27.01.2017Renewal fee patent year 06
29.01.2018Renewal fee patent year 07
28.01.2019Renewal fee patent year 08
27.01.2020Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.01.2012
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
[2023/27]
Former [2023/24]AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/40]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/24]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/11]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/08]CZ25.03.2020
DK25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/50]CZ25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/49]CZ25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/48]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/47]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/46]FI25.03.2020
HR25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/45]FI25.03.2020
HR25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/39]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/38]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
GR26.06.2020
Former [2020/37]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
Former [2020/35]FI25.03.2020
NO25.06.2020
Cited inInternational search[I]WO9401468  (MURST ITALIAN [IT]) [I] 1-9 * page 3, line 28 - page 4, line 8 * * page 41, line 24 - page 42, line 13 * * page 44, line 24 - page 45, line 25 *;
 [I]WO2008098019  (CARBYLAN BIOSURGERY INC [US], et al) [I] 1-9 * claims 1,27 * * page 38, lines 14-20 *;
 [I]WO2010015900  (ALLERGAN IND SAS [FR], et al) [I] 1-9* paragraphs [0014] , [0023] , [0044] *
ExaminationUS2011171311
 WO2011086458
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.